China Covid variant detected in Odisha!
China Covid variant detected in Odisha!
admin
Bhubaneswar: According to reports on Wednesday, at least three instances of Omicron subvariant BF.7, which appears to be the strain driving China's current rise of Covid infections, have been found in India, including one in Odisha.
Gujarat Biotechnology Research Centre discovered the first case of BF.7 in India in October. According to them, two cases have been recorded from Gujarat, while one case has been reported from Odisha.
According to official sources, the Omicron BF.7 Covid sub-variant was discovered in a single sample examined on September 30 in Odisha. The RT-PCR test was performed on the request of a woman from the Khurda district. RMRC sequenced this sample's genome.
It was neither a VOC (Variant of Concern) nor a VOI at the time of testing (Variant of Interest). In the three months since, no more BF.7 samples have been found in the state.
The woman was asymptomatic at the time of the test and was tested in preparation for her trip to the United States. She and her family have been in the United States since October. They claimed they had not experienced any flu-like symptoms since leaving India.
Experts noted at a Covid review meeting headed by Union Health Minister Mansukh Mandaviya on Wednesday that while there has been no overall increase in Covid caseload, there is a need for ongoing surveillance to keep track of existing and emerging varieties.
According to sources, Chinese cities are currently being affected by the highly transmissible Omicron strain, especially BF.7, which is the major variety circulating in Beijing and is contributing to a larger spike of Covid infections in the country.
According to the researchers, the BF.7's high transmissibility in China could be linked to a poor degree of immunity in the Chinese population from past infection and possibly vaccination.
According to sources, Chinese cities are currently being affected by the highly transmissible Omicron strain, especially BF.7, which is the major variety circulating in Beijing and is contributing to a larger spike of Covid infections in the country.
According to the researchers, the BF.7's high transmissibility in China could be linked to a poor degree of immunity in the Chinese population from past infection and possibly vaccination.
BF.7 is a sub-lineage of the Omicron variation BA.5, and it has the most infectious ability since it is highly transmissible, has a shorter incubation time, and has a greater capability to cause reinfection or infect even people who have been vaccinated.
It has already been discovered in several other countries, including the United States, the United Kingdom, and European countries such as Belgium, Germany, France, and Denmark.
